Par Pharmaceutical Shares Surge In Pre-Market On Acquisition News
Shares of Par Pharmaceutical Companies (NYSE: PRX) surged more than 36% in pre-market trading after the company agreed to be bought by the investment firm TPG for $50 per share in cash.
The deal price represents a 37% premium over Par Pharmaceutical's closing price on Friday.
Par Pharmaceutical shares jumped 36.41% to $49.90 in pre-market trading.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.